Savvy Updates 6/19/23: DIY vs. Commercial Closed-Loop Systems, Dexcom Private Deals w/ PBMs and How Senseonics Finds a Loophole, FDA’s Tap Program, Scoparia Dulcis & Retinopathy, Stress & Comfort Food, Which Sense Evolved First?, Doctors & “Moral Injury”
Do-It-Yourself (DIY) vs. Commercial Closed-Loop Systems for Managing Type 1 Diabetes, an upcoming presentation by Dana M. Lewis, developer of OpenAPS, to the American Diabetes Association 83rd Scientific Sessions, 23 June 2023. What is your presentation about? This...
Savvy Health, 6/14/23: Grapes & Microbiome, Almond Yogurt Best, Taurine Extends Life, Sucralose Damages DNA, Gratitude
Can consuming grapes daily increase certain gut bacteria? Gut bacteria – also known as the gut microbiome, microbiota, or microflora – play an important role in many areas of human health, including food digestion, immunity, and the regulation of brain...
Savvy D Living, 5/3/23: TCOYD on Carbs, Digestive Organs Vary, T1D in Hospital, T1D and Teeth, Burden of T1D Living, About Hair
TCOYD: All about Carb Counting with Drs. Steve Edelman and Jeremy Pettus These are 2 great videos (among many others) by TCOYD about carbs, carb counting and how to count fiber in your carb counting. I’ve always said that T1D would be WAY easier to manage...
Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?
Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage by Elise Reuter for MedTechDive.com, 17 April 2023. Since Medicare covers CGMs as durable medical equipment, the devices must include a component, such as a reader, that is...
Savvy Updates 4/17/23: ChatGPT as Diabetes Educator, Undbio Korean Insulin Comes to W. VA, 8000 Brisk Steps/Day, Blueberries, GoBag/DayPack, Who’s in Control in the Hospital?
Can ChatGPT Replace Diabetes Educators? Perhaps Not Yet by Liam Davenport for MedScape.com, 14 April 2023. ChatGPT, the novel artificial intelligence (AI) tool that has attracted interest and controversy in seemingly equal measure, can provide clear and...
More Diabetes Blogs